J&J to split up into two: what’s next for the stock?

Johnson & Johnson (NYSE: JNJ) is splitting up into two separate publicly traded companies, one focused on pharmaceutical and medical devices and the other on consumer products. Which of the two will attract more investors? According to Oppenheimer’s Jared Holz, once the split-up is complete, which is expected to take up to 24 months, the […]